Market Size of Transfer Membrane Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR (2024 - 2029) | 4.50 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Transfer Membrane Market Analysis
The Transfer Membrane Market is expected to register a CAGR of 4.5% during the forecast period.
The transfer membrane market is primarily driven by the increasing investment in R&D by pharmaceutical and biopharmaceutical companies and the development of new therapeutics for targeting chronic diseases. For instance, according to the European Commission Industrial R&D Investment prediction, data updated in December 2022, the United States planned to spend more than USD 679 billion on research and development in 2022. It was anticipated that China would spend roughly USD 551.1 billion on R&D in 2022. Hence, the high investment in R&D is believed to propel market growth as R&D opens doors for diagnostic research.
Furthermore, the growing prevalence of autoimmune and infectious diseases and the increasing focus on developing novel drug therapies based on DNA and RNA will boost market growth over the forecast period. According to the National Health Council data in March 2024, autoimmune diseases affect approximately 50 million Americans. More concerning is the trend, and the studies indicate an annual increase in autoimmune diseases of 3-12%, suggesting an almost epidemic rise. Therefore, the growing prevalence rate of autoimmune diseases is expected to increase R&D activities; in turn, the demand for transfer membranes is anticipated to upsurge. Eventually, these factors are expected to fuel the target market growth over the forecast period.
Moreover, in April 2022, Aviva Systems Biolocritical, a company that provides antibodies, immunoassay kits, and recombinant proteins for life sciences, launched its AvivaBlot product line of ECL reagents for western blot application. This new portfolio supports picogram to low femtogram detection of proteins via enhanced and stabilized chemiluminescent detection. Thus, the critical developments in the market, such as the increased launch and adoption of western blotting reagents, are also anticipated to foster the market’s growth due to the rise in the adoption of transfer membranes in western blot testing.
However, the availability of alternative methods for protein transfer with high efficiency and automation is anticipated to hamper the market growth.
Transfer Membrane Industry Segmentation
As per the scope, a transfer membrane is a microporous membrane used to detect and analyze proteins and nucleic acids. It is also used to transfer proteins from gel matrices and in various blotting techniques, such as northern, southern, western, and protein sequencing.
The transfer membrane market is segmented by type, transfer method, application, end-user, and geography. By type, the market is segmented into nitrocellulose transfer membrane, polyvinylidene fluoride (PVDF) transfer membrane, and nylon transfer membrane. By transfer method, the market is segmented into dry electrotransfer, semi-dry electrotransfer, and tank electrotransfer. By application, the transfer membrane market is segmented into western blotting, southern blotting, northern blotting, and other applications. By end user, the market is segmented into academic research institutions, pharmaceutical, biotechnological companies, and other end users. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD) for the abovementioned segments.
| By Type | |
| Nitrocellulose Transfer Membrane | |
| Polyvinylidene Fluoride (PVDF) Transfer Membrane | |
| Nylon Transfer Membrane |
| By Transfer Method | |
| Dry Electrotransfer | |
| Semi-Dry Electrotransfer | |
| Tank Elelctrotransfer |
| By Application | |
| Western Blotting | |
| Southern Blotting | |
| Northern Blotting | |
| Other Applications |
| By End User | |
| Academic Research Institutions | |
| Pharmacuitical and Biotechnological Companies | |
| Other End Users |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Transfer Membrane Market Size Summary
The transfer membrane market is poised for growth, driven by substantial investments in research and development by pharmaceutical and biopharmaceutical companies. This surge in R&D activities is largely fueled by the need to develop new therapeutics for chronic diseases, which in turn is expected to enhance the demand for transfer membranes. The increasing prevalence of autoimmune and infectious diseases, along with a focus on novel drug therapies based on DNA and RNA, further propels market expansion. Innovations such as the launch of advanced western blotting reagents, which improve protein detection capabilities, are also contributing to the market's growth. However, the emergence of alternative, highly efficient, and automated protein transfer methods may pose challenges to market expansion.
Regionally, North America is anticipated to hold a significant share of the transfer membrane market, supported by extensive R&D activities and substantial investments in drug development. The region's growth is further bolstered by the rising prevalence of chronic diseases and the increasing focus on targeted therapies. The market is characterized by a semi-consolidated landscape with key players like Merck KGaA, PerkinElmer Inc., and Thermo Fisher Scientific leading the charge. Strategic partnerships and collaborations, such as those between Bio-Techne and Cell Signaling Technology, are expected to enhance the adoption of western blot techniques, thereby driving market demand. Overall, the transfer membrane market is set to experience notable growth, supported by ongoing advancements and strategic initiatives within the industry.
Transfer Membrane Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Growing Prevalence of Targeted Diseases and Introduction of New Treatment Technologies
-
1.2.2 Growing Public and Private Investments in Research
-
-
1.3 Market Restraints
-
1.3.1 Lack of Skilled Professionals
-
1.3.2 Availability of Alternative Technologies
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD)
-
2.1 By Type
-
2.1.1 Nitrocellulose Transfer Membrane
-
2.1.2 Polyvinylidene Fluoride (PVDF) Transfer Membrane
-
2.1.3 Nylon Transfer Membrane
-
-
2.2 By Transfer Method
-
2.2.1 Dry Electrotransfer
-
2.2.2 Semi-Dry Electrotransfer
-
2.2.3 Tank Elelctrotransfer
-
-
2.3 By Application
-
2.3.1 Western Blotting
-
2.3.2 Southern Blotting
-
2.3.3 Northern Blotting
-
2.3.4 Other Applications
-
-
2.4 By End User
-
2.4.1 Academic Research Institutions
-
2.4.2 Pharmacuitical and Biotechnological Companies
-
2.4.3 Other End Users
-
-
2.5 Geography
-
2.5.1 North America
-
2.5.1.1 United States
-
2.5.1.2 Canada
-
2.5.1.3 Mexico
-
-
2.5.2 Europe
-
2.5.2.1 Germany
-
2.5.2.2 United Kingdom
-
2.5.2.3 France
-
2.5.2.4 Italy
-
2.5.2.5 Spain
-
2.5.2.6 Rest of Europe
-
-
2.5.3 Asia-Pacific
-
2.5.3.1 China
-
2.5.3.2 Japan
-
2.5.3.3 India
-
2.5.3.4 Australia
-
2.5.3.5 South Korea
-
2.5.3.6 Rest of Asia-Pacific
-
-
2.5.4 Middle East and Africa
-
2.5.4.1 GCC
-
2.5.4.2 South Africa
-
2.5.4.3 Rest of Middle East and Africa
-
-
2.5.5 South America
-
2.5.5.1 Brazil
-
2.5.5.2 Argentina
-
2.5.5.3 Rest of South America
-
-
-
Transfer Membrane Market Size FAQs
What is the current Transfer Membrane Market size?
The Transfer Membrane Market is projected to register a CAGR of 4.5% during the forecast period (2024-2029)
Who are the key players in Transfer Membrane Market?
Merck KGaA, PerkinElmer, Inc., Pall Corporation, Thermo Fisher Scientific and Bio-Rad Laboratories, Inc. are the major companies operating in the Transfer Membrane Market.
